
Ablaze Pharmaceuticals
A medical method that delivers radionuclides to tumor cells through targeted molecules to precisely kill cancer cells at close range, so as to achieve therapeutic purposes.
Employees
Enterprise value
$300—450m
Authorizing premium user...